RUNX2, a transcription factor involved in the differentiation and migration of osteoblasts and chondrocytes, activates transcriptional activity through the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, thereby promoting tumor progression and invasion.25 Here, AKT1 is linked to neoplasm.